Auranofin in rheumatoid arthritis
Champion, G.D.; Bieri, D.; Browne, C.D.; Day, R.O.; Graham, G.G.; Haavisto, T.M.; Sambrook, P.N.; Vallance, J.B.
Journal of Rheumatology. Suppl 8: 137-145
1982
ISSN/ISBN: 0380-0903 PMID: 6813475 Document Number: 195472
Document emailed within 1 workday
Related Documents
Blackburn, W.D. 1987: Auranofin: its use in patients with rheumatoid arthritis maintained with parenteral chrysotherapy Journal of Rheumatology 14(4): 863-864Champion, G.D.; Cairns, D.R.; Bieri, D.; Adena, M.A.; Browne, C.D.; Cohen, M.L.; Day, R.O.; Edmonds, J.P.; Graham, G.G.; de Jager, J. 1988: Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis Journal of Rheumatology 15(1): 28-34
Glennås, A.; Kvien, T.K.; Rugstad, H.E. 1986: Auranofin (Ridaura). a new peroral agent containing gold used in the treatment of rheumatoid arthritis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(29): 2438-2440
Michaels, R.M.; Reading, J.C.; Beezhold, D.H.; Ward, J.R. 1996: Serum phospholipase A2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two Journal of Rheumatology 23(2): 226-229
Yang, J.L. 1993: Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial Zhonghua Nei Ke Za Zhi 32(7): 486-488
Kuz'mina, N.N.; Brue, E.; Shaĭkov, A.V.; Isaeva, L.A.; Shakhbazian, I.E.; Giannini, E.; Iakovleva, A.A.; Puodzhiunene, E.P.; Vorontsov, I.M.; Astrauskene, D.S. 1990: The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research) Terapevticheskii Arkhiv 62(5): 38-41
Di Matteo, L.; D'Incecco, V.; Evangelista, L.; Castiglione, C.; Consoli, G. 1985: Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin) Bollettino della Societa Italiana di Biologia Sperimentale 61(5): 777-781
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Fantini, F.; Cottafava, F.; Martini, A.; Murelli, M.; Franchini, E.; D'Errico, R.; Panzarasa, R. 1986: Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis International Journal of Clinical Pharmacology Research 6(1): 61-67
Singh, N.; Garg, S.C. 1988: Rheumatoid arthritis presenting as arthritis mutilans with rheumatoid lung Journal of the Indian Medical Association 86(1): 14-15
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Lineker, S.C.; Badley, E.M.; Hughes, E.A.; Bell, M.J. 1997: Development of an instrument to measure knowledge in individuals with rheumatoid arthritis: the ACREU rheumatoid arthritis knowledge questionnaire Journal of Rheumatology 24(4): 647-653